digital therapeutics

News

Click bags FDA breakthrough tag for schizophrenia DTx

Digital health company Click Therapeutics has won an FDA breakthrough device designation for CT-155, a digital therapeutic (DTx) for the negative symptoms of schizophrenia

News

Vicore Pharma DTx helps pulmonary fibrosis patients

A digital therapeutic developed by Vicore Pharma and Alex Therapeutics has been shown to reduce the psychological burden of living with pulmonary fibrosis (PF) in a pivota

Digital

Why digital therapeutics (DTx) are effective and safe, but n...

In a new episode of the pharmaphorum podcast, host Nicole Raleigh welcomes Joel Morse, CEO and co-founder of Curavit Clinical Research, and Andy Molnar, CEO of the Digital Therapeutics Alli

News

Enrolment starts in trial of AI-powered Parkinson’s therapy

Patient recruitment is now underway in a clinical trial of Newel Health’s digital therapeutic for Parkinson’s disease, which hopes to show it can enhance the efficacy of t

News

Study finds trials of prescription DTx often lack ‘rigour’

A retrospective analysis of the clinical data supporting 20 FDA-approved prescription digital therapeutics has found that they often fail to apply rigorous standards of ev

News

Akili says OTC switch for ADHD DTx leads to sales rise

Akili Interactive’s decision to launch a non-prescription version of its digital therapeutic (DTx) for attention-deficit hyperactivity disorder (ADHD) is credited with an

Click bags FDA breakthrough tag for schizophrenia DTx

Vicore Pharma DTx helps pulmonary fibrosis patients

Why digital therapeutics (DTx) are effective and safe, but n...

Enrolment starts in trial of AI-powered Parkinson’s therapy

Study finds trials of prescription DTx often lack ‘rigour’

Akili says OTC switch for ADHD DTx leads to sales rise

CDMOs: Their crucial role and how to select one, with Sigma ...

How to meet your physicians where they are online

digital therapeutics

Editor's Picks